Market Executive Summary

REPORT HIGHLIGHT
The ?Global Active Pharmaceutical Ingredient Market- ? Industry Analysis, Share, Trend, Market Size and Forecast? was estimated to be around US$ 150.0 billion in 2017 and is anticipated to grow with 6.0% of growth rate during the future period. The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro-markets, the report also focuses on industry-specific drivers, restraints and opportunities in the Active Pharmaceutical Ingredient market. In terms of manufacturer segments of the Active Pharmaceutical Ingredient market Captive API market was the largest segment in 2017, and is expected to lose its share to merchant API market largely due to shift in trend towards CMO?s for API production. Based on synthesis, Synthetic API was the largest segment for Active pharmaceutical ingredient market by synthesis in 2017, but is expected to lose its share to biological API largely due to increasing demand of biosimilars. However, large investment in specialized containment and limited improvement in pharmaceutical facilities may reduce overall growth.
The market size and forecast for each segment has been provided for the period 2014 to 2028, considering 2017 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2017 to 2028 for every reported segment.
The scope of this report covers the Active Pharmaceutical Ingredient market by its major segments, which include the manufacturer, synthesis, drug type, therapeutic area and the major geographic regions. The years considered for the study are:
Historical Year ? 2014 & 2017
Base Year ? 2017
Estimated Year ? 2017
Projected Year ? 2028
Companies reported in this report are: Pfizer,Inc, Boehringer Ingelheim GmbH, Cambrex Corporation, Novartis AG, Lonza Group, Mylan N.V. and others. For company profiles in the report, 2014 has been considered. Where information is unavailable for the base year, the prior year has been considered.
TARGET AUDIENCE
Hospitals
Manufacturers
Traders, Distributors, And Suppliers of API Drugs
Government and Regional Agencies and Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The research report categorizes the Active Pharmaceutical Ingredient Market in each of the following submarkets to forecast the revenues and analyze the trends:
GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY MANUFACTURER
Captive
Merchant
GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY SYNHESIS
Synthetic
Biological
GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY DRUG TYPE
Generic
Branded
GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY THERAPEUTIC AREA
Cardiovascular
Metabolic
CNS
Oncology
Musculoskeletal
NSAIDS
Others
GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY REGION
North America
Europe
Asia Pacific
Rest of the World
GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, GEOGRAPHIC ANALYSIS
Further Breakdown of The North America Active Pharmaceutical Ingredient Market
U.S.
Canada
Further Breakdown of The Europe Active Pharmaceutical Ingredient Market
Germany
France
Rest of Europe
Further Breakdown of The APAC Active Pharmaceutical Ingredient Market
India
China
Rest of APAC
Further Breakdown of The Rest of the World Active Pharmaceutical Ingredient Market
Middle East and Africa
Latin America